期刊文献+

基质金属蛋白酶与动脉粥样硬化的研究进展 被引量:1

暂未订购
导出
出处 《中西医结合心脑血管病杂志》 2006年第9期802-803,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献16

  • 1Rajavashisth TB,Xu XP,Jovinge S.Membrane type Ⅰ matrix metalloproteinase expression in human atherosclerotic plaques:Evidence for activation by proinflammatory mediators[J].Circulation,1999,99:3103-3109.
  • 2于滢,杨向红.基质金属蛋白酶与动脉粥样硬化及斑块破裂的关系[J].中国动脉硬化杂志,2003,11(6):592-595. 被引量:38
  • 3Murphy G,Stanton H,Cowell S.Mechanisms for pro matrix metalloproteinase activation[J].APMIAS,1999.107:38-40.
  • 4边晓慧,李德天.MMPs表达与调控的研究进展[J].国外医学(泌尿系统分册),2004,24(1):136-139. 被引量:10
  • 5Schonbeck U,Mach F,Sukhovn GK,et al.Regulation of matrix metaloproteuiase expression in human vascular smooth muscle cells by T lymphocytea[J].Circ Res,1997,81:448-454.
  • 6Galis ZS,Muszynski M,Sukhova GK,et al.Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion[J].Circ Res,1994,75:181 -189.
  • 7Spinale FG,Coker ML,Heung LJ,et al.A matrix metaloproteuiase induction/activation systems exists in the human left ventricular myocardium and is upregulated in heart failure[J].Circulation,2000,102:1944-1949.
  • 8赵力群,司书毅.基质金属蛋白酶抑制剂研究进展[J].中国新药杂志,2004,13(6):494-498. 被引量:6
  • 9任冰稳.动脉粥样硬化与基质金属蛋白酶[J].中国循环杂志,2002,17(1):73-74. 被引量:33
  • 10Lee RT,Libby D.The unstable atherma[J].Aterioscler Thromb Vascular Biol,1997,17:1867-1959.

二级参考文献88

  • 1[1]Nagase H.Activation mechanis ms of matrix metalloproteinases.Biol Che m,1997,378:151-160.
  • 2[2]Brew K,Dinakarpandian D,Nagase H.Tissu e inhibitors of metalloproteinases:evolu tion,structure and function.Biochim Biop hys Acta,2000,1477:267-283.
  • 3[3]Rajavashisth TB,Xu XP,Jovinge S.Membra ne type 1 matrix metalloproteinase expre ssion in human atherosclerotic plaques:e vidence for activation by proinflammator y mediators.Circulation,1999,99:3103-310 9.
  • 4[4]Fitzgerald M,Hayward IP,Thomas AC,et al.Matrix metalloproteinase c an facilitate the heparanase-induced pro motion of phenotype change in vascular s mooth muscle cells.Atherosclerosis,1999, 145:97-106.
  • 5[5]Pasterkamp G,Schoneveld AH,Hijnen DJ,[ WTBZ〗et al.Atherosclerotic arteria l remodeling and the localization of mac rophages and matrix metalloproteases 1,2 and 9 in the human coronary artery.Athe rosclerosis,2000,150:245-253.
  • 6[6]Lee RT,Schoen FJ,Loree HM,et al[ WTBZ〗.Circumferential stress and matrix metalloproteinase 1 in human coronary at herosclerosis.Implications for plaque ru pture.Arterioscler Thromb Vasc Biol,1996 ,16:1070-1073.
  • 7[7]Sukhova GK,Schonbeck U,Rabkin E,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in v ulnerable human atheromatous plaques.Cir culation,1999,99:2503-2509.
  • 8[8]Lijinen HR,Soloway P,Collen D.Tissure inhibitor of matrix metalloproteinase-1 impairs arterial neointima formation aft er vascular injure in mice.Cir Res,1999, 85:1186-1191.
  • 9[9]Fukumoto Y,Libby P,Rabkin E.Statins al ter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic ra bbits.Circulation,2001,103:993-999.
  • 10[10]Bocan TM,Krause BR,Rosebury WS,e t al.The ACAT inhibitor avasimibe reduce s macrophages and matrix metalloproteina se expression in atherosclerotic lesions of hypercholesterolemic rabbits.Arterio scler Thromb Vasc Biol,2000,20:70-79.

共引文献82

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部